Intravenska emulzija masti u kliničkoj praksi: nutrijent i antidot

Mirtallo J, Dasta J, Kleinschmidt K, Varon J. State of the art review: Intravenous fat emulsions: Current applications, safety profile, and clinical implications. Ann Pharmacother 2010; 44(4): 688– 700.

Goulet O, Postaire M, De Potter S, Boya I, Jouniaux AM, Bereziat G, et al. Medium-chain triglycerides and long-term parenteral nu-trition in children. Nutrition 1992; 8(5): 333−7.

Jeejeebhoy KN. Total parenteral nutrition: potion or poison? Am J Clin Nutr 2001; 74(2): 160−3.

Mirković D, Antunović M, Putić V, Aleksić D. Stability investiga-tion of total parenteral nutrition admixture prepared in a hos-pital pharmacy. Vojnosanit Pregl 2008; 65(4): 286−90. (Ser-bian)

Carpentier Y, Simoens C, Siderova V, El Nakadi I, Vanweyenberg V, Eggerickx D, et al. Recent developments in lipid emulsions: relevance to intensive care. Nutrition 1997; 13(9): 73S −8S.

Puiggròs C, Sánchez J, Chacón P, Sabín P, Roselló J, Bou R, et al. Evolution of lipid profile, liver function, and pattern of plasma fatty acids according to the type of lipid emulsion administered in parenteral nutrition in the early postoperative period after digestive surgery. JPEN J Parenter Enteral Nutr 2009; 33(5): 501−12.

Weinberg G. LipidRescue™ Resuscitation. Available from: www.lipidrescue.org

Garcia-de-Lorenzo A, Lopez-Martinez J, Planas M, Chacon P, Montejo J, Bonet A, et al. Safety and metabolic tolerance of a con-centrated long-chain triglyceride lipid emulsion in critically ill septic and trauma patients. JPEN J Parenter Enteral Nutr 2003; 27(3): 208−15.

Intralipid 20%. Available from: www.accessdata.fda.gov/.../017643s072,084

Lee E, Simmer K, Gibson RA. Essential fatty acid deficiency in parenterally fed preterm infants. J Paediatr Child Health 1993; 29(1): 51−5.

Lutz O, Lave T, Frey A, Meraihi Z, Bach AC. Activites of lipo-protein lipase and hepatic lipase on long- and medium-chain triglyceride emulsions used in parenteral nutrition. Metabolism 1989; 38(6): 507−13.

Carpentier YA, Thonnart N. Parameters for evaluation of lipid metabolism. JPEN J Parenter Enteral Nutr 1987; 11(5 Suppl): 104S−8S.

Wretlind A. Development of fat emulsions. JPEN J Parenter Enteral Nutr 1981; 5(3): 230−5.

Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: a system-atic review of human and animal studies. Clin Toxicol (Phila) 2010; 48(1): 1−27.

Picard J, Harrop-Griffiths W. Lipid emulsion to treat drug over-dose: past, present and future. Anaesthesia 2009, 64(2): 119-21.

Cave G, Harvey M, Graudins A. Review article: Intravenous lipid emulsion as antidote: A summary of published human experi-ence. Emerg Med Australas 2011; 23(2): 123−41.

Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anestesiology 1998; 88(4): 1071−5.

Weinberg G. Lipid rescue resuscitation from local anaesthetic cardiac toxicity. Toxicol Rev 2006; 25(3): 139−45.

Cave G, Harvey M, Castle C. The role of fat emulsion therapy in a rodentmodel of propranolol toxicity: a preliminary study. J Med Toxicol 2006; 2(1): 4−7.

Bania T, Chu J, Perez E, Su M, Hahn IH. Hemodynamic effects of intravenous fat emulsions in an animal model of severe verapamil toxicity resuscitated with atropine calcium, and sa-line. Acad Emerg Med 2006; 13(2): 134−9.

Perez E, Bania T, Medlej K, Chu J, Mouravev R. Determining the optimal dose of intravenous fat emulsions for the treatment of severe verapamil toxicity in a rodent model. Acad Emerg Med 2008; 15(5 Suppl1): S92−3.

Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Acad Emerg Med 2007; 49(2): 178−85.

Harvey M, Cave G, Hoggett K. Correlation of plasma and perito-neal dialysate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits. Acad Emerg Med 2009; 16(2): 151−6.

Weinberg GL, Ripper R, Murphy P, Edelman LB, Hoffman W, Stri-chartz G, et al. Lipid infusion accelerates removal of bupiva-caine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med 2006, 31: 296–303.

Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescue dogs from bupivacaine-induced cardiac toxic-ity. Reg Anesth Pain Med 2003; 28(3): 198–202.

Stehr SN, Ziegeler JC, Pexa A, Oertel R, Deussen A, Koch T, et al. The effects of lipid infusion on myocardial function and bio-energetics in l-bupivacaine toxicity in the isolated rat heart. Anesth Analg 2007; 104(1): 186–92.

Eledjam JJ, de La Coussaye JE, Brugada J, Bassoul B, Gagnol JP, Fabregat JR, et al. In vitro study on mechanisms of bupiva-caine-induced depression of myocardial contractility. Anesth Analg 1989; 69(6): 732−5.

Van de Velde M, Wouters PF, Rolf N, Van Aken H, Flameng W, Vandermeersch E. Long-chain triglycerides improve recovery from myocardial stunning in conscious dogs. Cardiovasc Res 1996; 32(6): 1008−15.

Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA 1992; 89(14): 6452−6.

Florian JP, Pawelczyk JA. Non-esterified fatty acids increase ar-terial pressure via central sympathetic activation in humans. Clin Sci (Lond) 2009; 118(1): 61−9.

Di Gregorio G, Schwartz D, Ripper R, Kelly K, Feinstein DL, Min-shall RD, et al. Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac ar-rest. Crit Care Med 2009; 37(3): 993−9.

Ciechanowicz S, Patil V. Lipid emulsion for local anesthetic sys-temic toxicity. Anesthesiol Res Pract 2012; 2012: 131784.

Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006; 105(1): 217−8.

Litz RJ, Popp M, Stehr SN, Koch T. Successful resuscitation of a patient with ropivacain-induced asystole after axillary plexus block using lipid infusion Anesthesia 2006; 61(8): 800−1.

Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 2008; 51(4): 412−5.

Finn SD, Uncles DR, Willers J, Sable N. Early treatment of a quetiapine and sertraline overdose with Intralipid. Anesthesia 2009; 64(2): 191−4.

Young AC, Velez LI, Kleinschmidt KC. Intravenous fat emulsion therapy for the intentional sustained-release verapamil over-dose. Resuscitation 2009; 80(5): 591−3.

Harchelroad F, Palma A. Efficacy and safety of intravenous lipid therapy in a B- blocker overdose. Clin Toxicol 2008; 46(7): 634.

Dean P, Ruddy JP, Marshall S. Intravenous lipid emulsion on propranolol [corrected] overdose. Anaesthesia 2010; 65(11): 1148−50.

Jovic-Stosic J, Gligic B, Putic V, Brajkovic G, Spasic R. Severe pro-pranolol and ethanol overdose with wide complex tachycardia treated with intravenous lipid emulsion: A case report. Clin Toxicol (Phila) 2011; 49(5): 426–30.

Dolcourt B, Aaron C. Intravenous fat emulsion for refractory verapamil and atenolol induced shock: a human case report. Clin Toxicol 2008; 46(7): 619−20.

Carr D, Boone A, Hoffman RS, Martin K, Ahluwalia N. Successful resuscitation of carvedilol overdose using intravenous fat emulsion (IFE). Clin Toxicol 2009; 47(6): 726.

Stellpflug SJ, Harris CR, Engebretsen KM, Cole JB, Holger JS. Inten-tional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin. Clin Toxicol (Phila) 2010; 48(3): 227−9.

Guidelines for the Management of severe local Anaesthetic Toxicity. Association of Anaesthetists of Great Britain and Ire-land. Available from: http://www.aagbi.org/publications/guidelines/docs/latoxicity07.pdf. [accessed 2012 February].

Neal JM, Bernards CM, Butterworth JF 4th, Di Gregorio G, Drasner K, Hejtmanek MR, et al. ASRA Practice Advisory on Local An-esthetic Systemic Toxicity. Reg Anesth Pain Med 2010; 35(2): 152−61.

Sandstrom R, Hyltander A, Korner U, Lundholm K. Structured triglycerides were well tolerated and induced increased whole body fat oxidation compared with long-chain triglycerides in postoperative patients. JPEN J Parenter Enteral Nutr 1995; 19(5): 381−6.

Goulet O, Antébi H, Wolf C, Talbotec C, Alcindor LG, Corriol O, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double- blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010; 34(5): 485-95.

Chen FM, Wang JY, Sun LC, Juang RF, Huang TJ, Hsieh JS. Effi-cacy of medium-chain triglycerides compared with long-chain triglycerides in total parenteral nutrition in patients with diges-tive tract cancer undergoing surgery. Kaohsiung J Med Sci 2005; 21(11): 487−94.

Wirtitsch M, Wessner B, Spittler A, Roth E, Volk T, Bachman L, et al. Effect of different lipid emulsions on the immunological function in humans: a systematic reviw with meta-analysis. Clin Nutr 2007; 26(3): 302−13.

Picard J, Ward SC, Zumpe R, Meek T, Barlow J, Harrop-Griffiths W. Guidelines and the adoption of 'lipid rescue' therapy for local anaesthetic toxicity. Anaesthesia 2009; 64(2): 122−5.

Martin TG. Intravenous lipid emulsion therapy for poisoning. Abstracts of the XXVIII International Congress of the Euro-pean Association of Poison Centres and Clinical Toxicologists; 2008 May 6−9; Seville, Spain. Clin Toxicol 2008; 46(5): 403.

Weinberg G. Intravenous lipid emulsion: Why wait to save a life? Emerg Med Australas 2011; 23(2): 113−5.